< Back to Article

CD4-Specific Designed Ankyrin Repeat Proteins Are Novel Potent HIV Entry Inhibitors with Unique Characteristics

Table 2

Competition between DARPins and CD4-specific antibodies for binding to CD4.

doi: https://doi.org/10.1371/journal.ppat.1000109.t002